These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 25712746)

  • 1. Current frontiers in systemic sclerosis pathogenesis.
    Ciechomska M; van Laar J; O'Reilly S
    Exp Dermatol; 2015 Jun; 24(6):401-6. PubMed ID: 25712746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pathways as novel therapeutic targets in systemic sclerosis.
    Trojanowska M; Varga J
    Curr Opin Rheumatol; 2007 Nov; 19(6):568-73. PubMed ID: 17917537
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Angiogenesis Dysregulation in the Pathogenesis of Systemic Sclerosis.
    Cantatore FP; Maruotti N; Corrado A; Ribatti D
    Biomed Res Int; 2017; 2017():5345673. PubMed ID: 28791304
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Infectious disease as aetiological factor in the pathogenesis of systemic sclerosis.
    Radić M; Martinović Kaliterna D; Radić J
    Neth J Med; 2010 Nov; 68(11):348-53. PubMed ID: 21158008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Animal models of scleroderma: lessons from transgenic and knockout mice.
    Derrett-Smith EC; Denton CP; Sonnylal S
    Curr Opin Rheumatol; 2009 Nov; 21(6):630-5. PubMed ID: 19730378
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic approach to understanding the pathogenesis of systemic sclerosis.
    Zuo X; Zhang L; Luo H; Li Y; Zhu H
    Clin Genet; 2017 Oct; 92(4):365-371. PubMed ID: 27918067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of IL-13 in systemic sclerosis.
    Fuschiotti P
    Cytokine; 2011 Dec; 56(3):544-9. PubMed ID: 21920770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The immunobiology of systemic sclerosis.
    Gu YS; Kong J; Cheema GS; Keen CL; Wick G; Gershwin ME
    Semin Arthritis Rheum; 2008 Oct; 38(2):132-60. PubMed ID: 18221988
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel insights in the pathogenesis of systemic sclerosis.
    Radstake TR
    Expert Rev Clin Immunol; 2011 Jul; 7(4):389-90. PubMed ID: 21790277
    [No Abstract]   [Full Text] [Related]  

  • 11. Understanding systemic sclerosis through gene expression profiling.
    Pendergrass SA; Whitfield ML; Gardner H
    Curr Opin Rheumatol; 2007 Nov; 19(6):561-7. PubMed ID: 17917536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetics, the holy grail in the pathogenesis of systemic sclerosis.
    Altorok N; Almeshal N; Wang Y; Kahaleh B
    Rheumatology (Oxford); 2015 Oct; 54(10):1759-70. PubMed ID: 24740406
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Epigenetic Regulation of Scleroderma and Its Clinical Application.
    Luo Y; Xiao R
    Adv Exp Med Biol; 2020; 1253():375-403. PubMed ID: 32445102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathogenesis of systemic sclerosis.
    Katsumoto TR; Whitfield ML; Connolly MK
    Annu Rev Pathol; 2011; 6():509-37. PubMed ID: 21090968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic sclerosis: hypothesis-driven treatment strategies.
    Charles C; Clements P; Furst DE
    Lancet; 2006 May; 367(9523):1683-91. PubMed ID: 16714190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of toll-like receptors in systemic sclerosis.
    Ciechomska M; Cant R; Finnigan J; van Laar JM; O'Reilly S
    Expert Rev Mol Med; 2013 Aug; 15():e9. PubMed ID: 23985302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Systemic sclerosis--pathogenesis, clinical manifestations and treatment].
    Radić M; Kaliterna DM; Fabijanić D; Radić J
    Lijec Vjesn; 2010; 132(5-6):162-8. PubMed ID: 20677623
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Role of Epigenetic Modifications in Systemic Sclerosis: A Druggable Target.
    Henderson J; Distler J; O'Reilly S
    Trends Mol Med; 2019 May; 25(5):395-411. PubMed ID: 30858032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Updates in systemic sclerosis pathogenesis: Toward new therapeutic opportunities].
    Didier K; Robbins A; Antonicelli F; Pham BN; Giusti D; Servettaz A
    Rev Med Interne; 2019 Oct; 40(10):654-663. PubMed ID: 31301944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic sclerosis. Part 2. Epigenetic factors in the pathogenesis of clinical manifestations].
    Fryc J; Midro AT; Panasiuk B; Sierakowski S
    Przegl Lek; 2015; 72(1):25-30. PubMed ID: 26076574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.